Cannon Advisors, Inc. Novo Nordisk A S Call Options Transaction History
Cannon Advisors, Inc.
- $109 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NVO
# of Institutions
1,742Shares Held
338MCall Options Held
10.9MPut Options Held
15.9M-
Jennison Associates LLC18.9MShares$965 Million0.78% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$756 Million0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$633 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$629 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$606 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $115B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...